
United States · Defense & space startup
Rosotics is a deeptech startup founded in 2019, specializing in hyper-efficient metal additive manufacturing through its proprietary Rapid Induction PrintingTM technology.
Funding reportedLast round: Pre-seed
Rosotics is a deeptech startup founded in 2019, specializing in hyper-efficient metal additive manufacturing through its proprietary Rapid Induction PrintingTM technology.
The company has transitioned from selling industrial printers to becoming a space infrastructure company focused on building autonomous orbital systems. Headquartered in Cape Canaveral, Florida, Rosotics aims to address challenges in defense and aerospace by creating large-scale structures with reduced energy and material usage compared to traditional methods. The company utilizes its innovative induction-based metal 3D printing technology to produce massive structures efficiently. Key platforms include the Halo printer, designed for internal production of autonomous orbital systems, and the M1, the largest commercially available metal 3D printer. Rosotics operates under a "Space 3D Printing as a Service" model, focusing on orbital manufacturing and defense hardware production. Its target sectors include aerospace, defense, naval/maritime, and energy, serving a B2B market with advanced manufacturing solutions.
Funding, as reported
What they build
Known for
industrial automationindustrial engineeringmanufacturingspace manufacturing platformsenergy-efficient manufacturinginformation technology & servicesspacecraft thermal managementspace industryorbital manufacturinglong-term space factory deploymentenvironmental servicesdefenselarge-scale structureshyper-efficient metal 3d printingspace sector solutionsspace manufacturing
Built with from their website
Google App EngineGoogle CloudViewport MetaVarnishwebpackGoogle Cloud HostingPriority HintsReactSirvoyWix eCommerce
MySQLWebsiteBuilderMobile FriendlyLodashOpen GraphRSSGoogle Cloud CDNWordpress.com
Add your raise, your deck and your story, and put Rosotics in front of investors. Or tell us what we have wrong.